ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析

◆英語タイトル:ChemoCentryx Inc (CCXI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140080FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company’s lead drug candidate include Avacopan, an orally-administered complement inhibitor of the complement C5a receptor (C5aR), for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CCX872, an orally administered inhibitor for pancreatic cancer; and CCX140, an orally-administered inhibitor of the chemokine receptor known for patients with diabetic nephropathy, among others. It also carries out preclinical research for evaluating the effect of combination therapy with chemokine receptor and check point inhibitors. ChemoCentryx is headquartered in Mountain View, California, the US.

ChemoCentryx Inc Key Recent Developments

Apr 07,2021: ChemoCentryx to Host Virtual R&D Day on April 14, 2021
Mar 02,2021: ChemoCentryx Announces Appointment of Susan M. Kanaya to Board of Directors
Feb 24,2021: ChemoCentryx Appoints Tausif (‘Tosh’) Butt as Executive Vice President and Chief Operating Officer

This comprehensive SWOT profile of ChemoCentryx Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ChemoCentryx Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

ChemoCentryx Inc – Key Information
ChemoCentryx Inc – Overview
ChemoCentryx Inc – Key Employees
ChemoCentryx Inc – Key Employee Biographies
ChemoCentryx Inc – Key Operational Heads
ChemoCentryx Inc – Major Products and Services
ChemoCentryx Inc – History
ChemoCentryx Inc – Company Statement
ChemoCentryx Inc – Locations And Subsidiaries
ChemoCentryx Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ChemoCentryx Inc – Business Description
ChemoCentryx Inc – Corporate Strategy
ChemoCentryx Inc – SWOT Analysis
SWOT Analysis – Overview
ChemoCentryx Inc – Strengths
ChemoCentryx Inc – Weaknesses
ChemoCentryx Inc – Opportunities
ChemoCentryx Inc – Threats
ChemoCentryx Inc – Key Competitors

Section 3 – Company Financial Performance Charts

ChemoCentryx Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ChemoCentryx Inc, Key Information
ChemoCentryx Inc, Key Ratios
ChemoCentryx Inc, Share Data
ChemoCentryx Inc, Major Products and Services
ChemoCentryx Inc, History
ChemoCentryx Inc, Key Employees
ChemoCentryx Inc, Key Employee Biographies
ChemoCentryx Inc, Key Operational Heads
ChemoCentryx Inc, Other Locations
ChemoCentryx Inc, Subsidiaries
ChemoCentryx Inc, Key Competitors
ChemoCentryx Inc, SWOT Analysis
ChemoCentryx Inc, Ratios based on current share price
ChemoCentryx Inc, Annual Ratios
ChemoCentryx Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Epsilon Energy Ltd (EPS):企業の財務・戦略的SWOT分析
    Summary Epsilon Energy Ltd (Epsilon) is an oil and gas company that provides exploration, exploitation and development of oil and gas reserves. The company provides projects such as Marcellus shale in northeast Pennsylvania, Bakken Shale and Midale Dolomite in Saskatchewan, among others. It operates …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fairfax Financial Holdings Limited:企業の戦略・SWOT・財務情報
    Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Financial Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Kootenai Electric Cooperative, Inc.:発電所・企業SWOT分析
    Kootenai Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • WB Electronics SA :企業の戦略・SWOT・財務情報
    WB Electronics SA - Strategy, SWOT and Corporate Finance Report Summary WB Electronics SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PharmaCyte Biotech Inc (PMCB):企業の財務・戦略的SWOT分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Graybug Vision Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Graybug Vision Inc (Graybug Vision) is a clinical stage pharmaceutical company that develops next generation products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company’s lead candidate include GB-102, a clinical-stage depot formulation of sun …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Elk Petroleum Ltd (ELK):石油・ガス:M&Aディール及び事業提携情報
    Summary Elk Petroleum Ltd (Elk) is an oil and gas company that explore, produce, and develops oil and gas properties. The company operates projects in Grieve oil field and Singleton oil field. Its Grieve oil field development project is a joint venture between the company and Denbury Resources, a pe …
  • Emera Inc:発電所・企業SWOT分析
    Emera Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Fortis Inc (FTS):電力:M&Aディール及び事業提携情報
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • EMS SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EMS SA (EMS) is a pharmaceutical company, which is focused in the development of products for improvement of health and well-being of the population. It operates in prescription segments generics, branded pharmaceuticals, OTC and hospital. It has presence in the US market through Brace Pharm …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ASML Holding N.V.:企業の戦略・SWOT・財務分析
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Weatherford International Plc (WFT):石油・ガス:M&Aディール及び事業提携情報
    Summary Weatherford International Plc (Weatherford) is an oilfield service provider. The company offers equipment and services utilized in the drilling, evaluation, completion, production and intervention of oil and natural gas wells. Its product line includes artificial lift systems, completion sys …
  • Dyas BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Dyas BV (Dyas) a subsidiary of SHV Holdings N.V., is an oil and gas company that offers oil exploration and production programs. The company offers products which include crude oil and natural gas. It operates projects which include Buzzard, Broom, Elgin and Franklin; Bergen, Middelie, Zuid …
  • Essilor International Compagnie Generale d’Optique SA (EI):医療機器:M&Aディール及び事業提携情報
    Summary Essilor International Compagnie Generale d'Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆